NR3C2 and cardiac hypertrophy: In addition, MR deficiency in myeloid cells mimics the effects of MR antagonists and protects against cardiac hypertrophy, fibrosis, and vascular damage caused by N omega-Nitro-L-arginine methyl ester hydrochloride (L-NAME) and angiotensin II [38].